Today's Daily Dose brings you news about EDAP's strong financial results, anticipated milestones of Ascendis Pharma; FDA approval of a new add-on drug to treat "Off episodes" in Parkinson's and the clinical trial catalysts of Mirum Pharma.
from RTT - Biotech https://ift.tt/2Zpz3gH
via IFTTT
No comments:
Post a Comment